Literature DB >> 21385704

Cancer. New epigenetic drivers of cancers.

Simon J Elsässer1, C David Allis, Peter W Lewis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21385704     DOI: 10.1126/science.1203280

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  32 in total

1.  N6-methyladenine DNA Modification in Glioblastoma.

Authors:  Qi Xie; Tao P Wu; Ryan C Gimple; Zheng Li; Briana C Prager; Qiulian Wu; Yang Yu; Pengcheng Wang; Yinsheng Wang; David U Gorkin; Cheng Zhang; Alexis V Dowiak; Kaixuan Lin; Chun Zeng; Yinghui Sui; Leo J Y Kim; Tyler E Miller; Li Jiang; Christine H Lee; Zhi Huang; Xiaoguang Fang; Kui Zhai; Stephen C Mack; Maike Sander; Shideng Bao; Amber E Kerstetter-Fogle; Andrew E Sloan; Andrew Z Xiao; Jeremy N Rich
Journal:  Cell       Date:  2018-11-01       Impact factor: 41.582

2.  Histone chaperones link histone nuclear import and chromatin assembly.

Authors:  Kristin M Keck; Lucy F Pemberton
Journal:  Biochim Biophys Acta       Date:  2011-10-08

3.  ATRX contributes to epigenetic asymmetry and silencing of major satellite transcripts in the maternal genome of the mouse embryo.

Authors:  Rabindranath De La Fuente; Claudia Baumann; Maria M Viveiros
Journal:  Development       Date:  2015-04-29       Impact factor: 6.868

Review 4.  Super-enhancer function and its application in cancer targeted therapy.

Authors:  Faqing Tang; Zongbei Yang; Yuan Tan; Yuejin Li
Journal:  NPJ Precis Oncol       Date:  2020-02-12

5.  Silencing of the DNA mismatch repair gene MLH1 induced by hypoxic stress in a pathway dependent on the histone demethylase LSD1.

Authors:  Yuhong Lu; Narendra Wajapeyee; Mitchell S Turker; Peter M Glazer
Journal:  Cell Rep       Date:  2014-07-17       Impact factor: 9.423

Review 6.  Role of ATRX in chromatin structure and function: implications for chromosome instability and human disease.

Authors:  Rabindranath De La Fuente; Claudia Baumann; Maria M Viveiros
Journal:  Reproduction       Date:  2011-06-08       Impact factor: 3.906

Review 7.  Translational research in neuroendocrine tumors: pitfalls and opportunities.

Authors:  J Capdevila; O Casanovas; R Salazar; D Castellano; A Segura; P Fuster; J Aller; R García-Carbonero; P Jimenez-Fonseca; E Grande; J P Castaño
Journal:  Oncogene       Date:  2016-09-19       Impact factor: 9.867

8.  Selective inhibition of tumor oncogenes by disruption of super-enhancers.

Authors:  Jakob Lovén; Heather A Hoke; Charles Y Lin; Ashley Lau; David A Orlando; Christopher R Vakoc; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

9.  Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma.

Authors:  Peter W Lewis; Manuel M Müller; Matthew S Koletsky; Francisco Cordero; Shu Lin; Laura A Banaszynski; Benjamin A Garcia; Tom W Muir; Oren J Becher; C David Allis
Journal:  Science       Date:  2013-03-28       Impact factor: 47.728

10.  Histone mimics: digging down under.

Authors:  Yiwei Lin; Binhua P Zhou
Journal:  Front Biol (Beijing)       Date:  2013-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.